These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16245318)

  • 1. Akt activation correlates with adverse outcome in tongue cancer.
    Massarelli E; Liu DD; Lee JJ; El-Naggar AK; Lo Muzio L; Staibano S; De Placido S; Myers JN; Papadimitrakopoulou VA
    Cancer; 2005 Dec; 104(11):2430-6. PubMed ID: 16245318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological presentation of tongue cancers and early cancer treatment.
    Najeeb T
    J Coll Physicians Surg Pak; 2006 Mar; 16(3):179-82. PubMed ID: 16542596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110alpha in squamous cell carcinoma of the oral tongue.
    Estilo CL; O-Charoenrat P; Ngai I; Patel SG; Reddy PG; Dao S; Shaha AR; Kraus DH; Boyle JO; Wong RJ; Pfister DG; Huryn JM; Zlotolow IM; Shah JP; Singh B
    Clin Cancer Res; 2003 Jun; 9(6):2300-6. PubMed ID: 12796399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of activated Akt expression in oral squamous cell carcinoma.
    Lim J; Kim JH; Paeng JY; Kim MJ; Hong SD; Lee JI; Hong SP
    J Clin Pathol; 2005 Nov; 58(11):1199-205. PubMed ID: 16254112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acid synthase expression in squamous cell carcinoma of the tongue: clinicopathological findings.
    Silva SD; Perez DE; Nishimoto IN; Alves FA; Pinto CA; Kowalski LP; Graner E
    Oral Dis; 2008 May; 14(4):376-82. PubMed ID: 18410580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Postoperative recurrence-related factors of 125 patients with cT1-2N0 squamous cell carcinoma of the oral tongue].
    Han JM; Wu GH; Zeng ZY; Chen FJ; Chen WK; Li H; Song M; Sun CZ
    Ai Zheng; 2007 Jun; 26(6):661-5. PubMed ID: 17562277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapse patterns and related prognostic factors in patients with mobile tongue cancer treated with postoperative radiotherapy.
    Kamer S; Esassolak M; Demirci S; Akyildiz S; Sengul A; Yavuzer A
    J BUON; 2009; 14(1):51-6. PubMed ID: 19373947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions.
    Balsara BR; Pei J; Mitsuuchi Y; Page R; Klein-Szanto A; Wang H; Unger M; Testa JR
    Carcinogenesis; 2004 Nov; 25(11):2053-9. PubMed ID: 15240509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of contralateral N0 neck in early squamous cell carcinoma of the oral tongue: elective neck dissection versus observation.
    Lim YC; Lee JS; Koo BS; Kim SH; Kim YH; Choi EC
    Laryngoscope; 2006 Mar; 116(3):461-5. PubMed ID: 16540910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The results of combined treatment (surgery and postoperative radiotherapy) for tongue cancer and prognostic factors].
    Karadeniz A; Saynak M; Kadehci Z; Fayda M; Aksu G; Kocaelli H; Hafiz G
    Kulak Burun Bogaz Ihtis Derg; 2007; 17(1):1-6. PubMed ID: 17483603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Squamous cell carcinoma of the oral tongue: a 25-year, single institution experience.
    Mosleh-Shirazi MS; Mohammadianpanah M; Mosleh-Shirazi MA
    J Laryngol Otol; 2009 Jan; 123(1):114-20. PubMed ID: 18588737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma.
    Rusthoven K; Ballonoff A; Raben D; Chen C
    Cancer; 2008 Jan; 112(2):345-51. PubMed ID: 18041071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective randomized study of selective neck dissection versus observation for N0 neck of early tongue carcinoma.
    Yuen AP; Ho CM; Chow TL; Tang LC; Cheung WY; Ng RW; Wei WI; Kong CK; Book KS; Yuen WC; Lam AK; Yuen NW; Trendell-Smith NJ; Chan YW; Wong BY; Li GK; Ho AC; Ho WK; Wong SY; Yao TJ
    Head Neck; 2009 Jun; 31(6):765-72. PubMed ID: 19408291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tongue cancer: Is there a difference in survival compared with other subsites in the oral cavity?
    Bell RB; Kademani D; Homer L; Dierks EJ; Potter BE
    J Oral Maxillofac Surg; 2007 Feb; 65(2):229-36. PubMed ID: 17236926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral tongue cancer in young patients: a matched analysis.
    Garavello W; Spreafico R; Gaini RM
    Oral Oncol; 2007 Oct; 43(9):894-7. PubMed ID: 17307026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxiredoxin I expression in tongue squamous cell carcinomas as involved in tumor recurrence.
    Yanagawa T; Omura K; Harada H; Ishii T; Uwayama J; Nakaso K; Iwasa S; Koyama Y; Onizawa K; Yusa H; Yoshida H
    Int J Oral Maxillofac Surg; 2005 Dec; 34(8):915-20. PubMed ID: 15955662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer.
    Mudduluru G; Medved F; Grobholz R; Jost C; Gruber A; Leupold JH; Post S; Jansen A; Colburn NH; Allgayer H
    Cancer; 2007 Oct; 110(8):1697-707. PubMed ID: 17849461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of phosphorylated Akt in oral carcinogenesis and its induction by nicotine and alkaline stimulation.
    Wu HT; Ko SY; Fong JH; Chang KW; Liu TY; Kao SY
    J Oral Pathol Med; 2009 Feb; 38(2):206-13. PubMed ID: 18331557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic role of loss of insulin-like growth factor-binding protein-3 expression in head and neck carcinogenesis.
    Papadimitrakopoulou VA; Brown EN; Liu DD; El-Naggar AK; Jack Lee J; Hong WK; Lee HY
    Cancer Lett; 2006 Jul; 239(1):136-43. PubMed ID: 16181731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activation of Akt during preoperative chemotherapy for esophageal cancer correlates with poor prognosis.
    Yoshioka A; Miyata H; Doki Y; Yasuda T; Yamasaki M; Motoori M; Okada K; Matsuyama J; Makari Y; Sohma I; Takiguchi S; Fujiwara Y; Monden M
    Oncol Rep; 2008 May; 19(5):1099-107. PubMed ID: 18425364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.